Combined Analysis of Phase III Trials Evaluating [(99m)Tc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma.
Ann. Surg. Oncol., Oct (2012)
Utilization of Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In Situ Undergoing Mastectomy.
Ann. Surg. Oncol., Sep (2012)
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.
Anticancer Res., Sep;32(9):3911-5 (2012)
Treatment options for metaplastic breast cancer.
ISRN Oncol., 2012:706162 (2012)
Rural-urban disparities in use of post-lumpectomy radiation.
Med. Oncol., Dec;29(5):3250-7 (2012)
Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma.
J Surg Oncol., Dec;106(7):807-10 (2012)
P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
Hum. Pathol., Nov;43(11):1948-54 (2012)
Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy.
J. Surg. Res., Sep;177(1):e21-6 (2012)
Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.
Med. Oncol., Sep;29(3):1523-8 (2012)
Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors.
Arch Dermatol., Sep;147(9):1058-62 (2011)
Predicting survival for well-differentiated liposarcoma: the importance of tumor location.
J. Surg. Res., Jun;175(1):12-7 (2012)
Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma.
Ann. Surg. Oncol., Feb;19(2):504-10 (2012)
Do radiation use disparities influence survival in patients with advanced breast cancer?
Cancer., Jan;118(1):196-204 (2012)
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention.
Ann. Surg., Aug;254(2):333-8 (2011)
Outcomes for lymph node-positive cutaneous melanoma over two decades.
World J Surg., Jul;35(7):1567-72 (2011)
Surgical resident involvement is safe for common elective general surgery procedures.
J. Am. Coll. Surg., Jul;213(1):19-26; discussion 26-8 (2011)
Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis.
J. Surg. Res., Jun;168(2):e173-80 (2011)
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
Melanoma Res., Jun;21(3):235-43 (2011)
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis.
J Surg Oncol., Apr;103(5):390-4 (2011)
Tumor location predicts survival in cutaneous head and neck melanoma.
J. Surg. Res., May;167(2):192-8 (2011)
Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.
Plast. Reconstr. Surg., Dec;126(6):1815-24 (2010)
Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
J. Surg. Res., Jan;172(1):123-30 (2012)
Adjuvant external beam radiation for medullary thyroid carcinoma.
J Surg Oncol., Aug;102(2):175-8 (2010)
Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.
Int. J. Radiat. Oncol. Biol. Phys., Nov;78(3):787-92 (2010)
Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast.
J Surg Oncol., Sep;102(4):342-7 (2010)
Metaplastic breast cancer: to radiate or not to radiate?
Ann. Surg. Oncol., Jan;18(1):94-103 (2011)
Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma.
Ann. Surg. Oncol., Oct;17(10):2578-84 (2010)
Medullary carcinoma of the breast: a population-based perspective.
Med. Oncol., Sep;28(3):738-44 (2011)
An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.
Am Surg., Jan;76(1):28-32 (2010)
Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas.
J. Am. Coll. Surg., Feb;210(2):191-198.e2 (2010)
Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era.
Med. Oncol., Dec;27(4):1420-4 (2010)
Initial characterization of a dedicated breast PET/CT scanner during human imaging.
J. Nucl. Med., Sep;50(9):1401-8 (2009)
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Clin. Cancer Res., May;15(9):2988-94 (2009)
Multimarker circulating DNA assay for assessing blood of prostate cancer patients.
Clin. Chem., Mar;55(3):559-67 (2009)
The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence.
Am. J. Surg., Oct;196(4):495-9 (2008)
Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Ann. Surg. Oncol., Sep;15(9):2493-9 (2008)
A rational surgical approach to the treatment of distant melanoma metastases.
Cancer Treat. Rev., Nov;34(7):614-20 (2008)
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.
Cancer., Mar;112(5):1162-8 (2008)
Metastatic breast cancer mimicking benign fatty liver infiltration.
Breast J., 14(1):108 (2008 Jan-Feb)
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
Clin. Cancer Res., Jul;13(14):4105-10 (2007)
Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.
Cancer Res., Dec;66(24):11825-30 (2006)
Treatment disparities in Hispanic rectal cancer patients: a SEER database study.
Am Surg., Oct;72(10):906-8 (2006)
The role of surgery in treatment of stage IV melanoma.
J Surg Oncol., Sep;94(4):344-51 (2006)
Estrogen receptor-alpha methylation predicts melanoma progression.
Cancer Res., Jul;66(13):6692-8 (2006)
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?
Cancer J., 12(3):207-11 (2006 May-Jun)
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Ann. Surg., Jul;244(1):113-20 (2006)
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.
Cancer Res., Jun;66(12):6111-7 (2006)
Sentinel lymph node mapping with GI cancer.
Cancer Metastasis Rev., Jun;25(2):269-77 (2006)
Molecular upstaging of sentinel lymph nodes in melanoma: where are we now?
Surg. Oncol. Clin. N. Am., Apr;15(2):331-40 (2006)
Colorectal cancer screening and surveillance: current standards and future trends.
Ann. Surg. Oncol., Jun;13(6):768-75 (2006)
The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
Am. J. Surg., Feb;191(2):281-3 (2006)
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.
J. Clin. Oncol., Dec;23(36):9351-8 (2005)
The clinical significance of MAGEA3 expression in pancreatic cancer.
Int. J. Cancer., May;118(9):2269-75 (2006)
Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
J. Cell. Biochem., Oct;96(3):473-83 (2005)
Quality control issues in the management of colon cancer patients.
Eur J Surg Oncol., Aug;31(6):616-29 (2005)
Lymphatic mapping and sentinel node analysis in colon cancer.
Clin Colorectal Cancer., Jan;4(5):320-4 (2005)
Novel effective drugs and evolving ablation technology: a more comprehensive approach to hepatic malignancies.
Ann. Surg. Oncol., May;11(5):458-9 (2004)